Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock - Foreign
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
870,576
-
Shares change
-
+25,429
-
Total reported value, excl. options
-
$25,403,812
-
Value change
-
+$742,207
-
Number of buys
-
2
-
Price
-
$29.20
Institutional Holders of Takeda Pharmaceutical Co Ltd - Common Stock - Foreign as of Q3 2025
As of 30 Sep 2025 Takeda Pharmaceutical Co Ltd - Common Stock - Foreign had 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 870,576 shares of stock of the company.
Largest 2 holders included Pacer Advisors, Inc. and PARADIGM ASSET MANAGEMENT CO LLC.
This table shows 2 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.